Literature DB >> 16107156

QSAR studies of copper azamacrocycles and thiosemicarbazones: MM3 parameter development and prediction of biological properties.

Peter Wolohan1, Jeongsoo Yoo, Michael J Welch, David E Reichert.   

Abstract

Genetic algorithms (GA) were used to develop specific copper metal-ligand force field parameters for the MM3 force field, from a combination of crystallographic structures and ab initio calculations. These new parameters produced results in good agreement with experiment and previously reported copper metal-ligand parameters for the AMBER force field. The MM3 parameters were then used to develop several quantitative structure-activity relationship (QSAR) models. A successful QSAR for predicting the lipophilicity (log P(ow)) of several classes of Cu(II)-chelating ligands was built using a training set of 32 Cu(II) radiometal complexes and 6 simple molecular descriptors. The QSAR exhibited a correlation between the predicted and experimental log P(ow) with an r(2) = 0.95, q(2) = 0.92. When applied to an external test set of 11 Cu(II) complexes, the QSAR preformed with great accuracy; r(2) = 0.93 and a q(2) = 0.91 utilizing a leave-one-out cross-validation analysis. Additional QSAR models were developed to predict the biodistribution of a smaller set of Cu(II) bis(thiosemicarbazone) complexes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107156      PMCID: PMC2566539          DOI: 10.1021/jm0501376

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

1.  Molden: a pre- and post-processing program for molecular and electronic structures.

Authors:  G Schaftenaar; J H Noordik
Journal:  J Comput Aided Mol Des       Date:  2000-02       Impact factor: 3.686

2.  Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.

Authors:  Y Fujibayashi; H Taniuchi; Y Yonekura; H Ohtani; J Konishi; A Yokoyama
Journal:  J Nucl Med       Date:  1997-07       Impact factor: 10.057

Review 3.  Cyclooxygenase (COX) inhibitors: a comparative QSAR study.

Authors:  Rajni Garg; Alka Kurup; Suresh Babu Mekapati; Corwin Hansch
Journal:  Chem Rev       Date:  2003-03       Impact factor: 60.622

Review 4.  Reliability of logP predictions based on calculated molecular descriptors: a critical review.

Authors:  D Eros; I Kövesdi; L Orfi; K Takács-Novák; Gy Acsády; Gy Kéri
Journal:  Curr Med Chem       Date:  2002-10       Impact factor: 4.530

5.  Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents.

Authors:  J Easmon; G Heinisch; W Holzer; B Rosenwirth
Journal:  J Med Chem       Date:  1992-08-21       Impact factor: 7.446

6.  QSAR and ADME.

Authors:  Corwin Hansch; Albert Leo; Suresh Babu Mekapati; Alka Kurup
Journal:  Bioorg Med Chem       Date:  2004-06-15       Impact factor: 3.641

7.  64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

Authors:  C J Anderson; F Dehdashti; P D Cutler; S W Schwarz; R Laforest; L A Bass; J S Lewis; D W McCarthy
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

8.  Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution.

Authors:  Jeongsoo Yoo; David E Reichert; Michael J Welch
Journal:  J Med Chem       Date:  2004-12-16       Impact factor: 7.446

9.  Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships.

Authors:  Jason L J Dearling; Jason S Lewis; Gregory E D Mullen; Michael J Welch; Philip J Blower
Journal:  J Biol Inorg Chem       Date:  2001-09-08       Impact factor: 3.358

10.  Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.

Authors:  M K Moi; C F Meares; M J McCall; W C Cole; S J DeNardo
Journal:  Anal Biochem       Date:  1985-07       Impact factor: 3.365

View more
  2 in total

1.  Enhanced antitumor effect of L-buthionine sulfoximine or ionizing radiation by copper complexes with 2,2´-biquinoline and sulfonamides on A549 2D and 3D lung cancer cell models.

Authors:  J F Cadavid Vargas; C Villa Perez; D B Soria; A Guerci; A L Di Virgilio
Journal:  J Biol Inorg Chem       Date:  2022-03-05       Impact factor: 3.358

Review 2.  CoMSIA and docking study of rhenium based estrogen receptor ligand analogs.

Authors:  Peter Wolohan; David E Reichert
Journal:  Steroids       Date:  2007-02-05       Impact factor: 2.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.